summit 2024 web banner 1402

Liverpool, 9th - 11th July 2024


This year we are bringing the community together for the first national patient-focused conference in the UK for secondary (metastatic) breast cancer. 


Becoming your own advocate is an integral part of living alongside secondary breast cancer. We know how challenging it can be to navigate the world of medical terminology and clinical guidelines, so we are creating an event that will empower our community through increased knowledge and understanding of research, treatments and options.

Live Q&As with our panel of experts

Interactive exhibition stalls

Social spaces and a community café

With a 'choose your own adventure' style programme, you will be able to dip into topics that feel right for you. We will be covering the latest developments for each subtype, exploring personalised treatments, finding out more about clinical trials and tackling difficult conversations around secondary breast cancer. 


A live streaming service on the day will make the educational content available to the community at home. Register here to join.


Prof Carlo Palmieri, Secondary Breast Cancer Summit Clinical Lead

The Secondary Breast Cancer Summit is the first national patient-focused conference in the UK for secondary (metastatic) breast cancer. 

In response to invaluable insights from recent LIMBER and Metastatic Breast Cancer research studies funded by the Make 2nds Count, we've identified critical knowledge gaps within the secondary breast cancer community, and the Summit will address these. From disease understanding to clinical trials, treatment, and side effects, our bespoke event programme will meet the research information needs of the secondary breast cancer community. Our goal is to educate and empower patients, and help them feel more confident in their understanding of the disease.

Lesley Stephen, Secondary Breast Cancer Summit Patient Lead

I’m delighted that we are launching this first UK summit for patients with secondary breast cancer.  I’ve been living with secondary breast cancer for 10 years, and in that time I have been to many cancer conferences with medical talks that can be difficult to follow if you don’t have a science background.  

I’ve often thought it would be great to offer secondary breast cancer patients the opportunity to have their own conference, ask researchers and clinicians questions about their work and find out about the latest treatments, but all presented in a way that we patients can understand. I‘d encourage you to sign up for this unique event, enjoy the programme we are putting together for you and I look forward to seeing you in Liverpool in July.

Talks Programme

Each speaker session will include a 20 minute talk and a 20 minute Q&A. 

Wednesday 10th July 


9.15 - 9.45am

Prof David Cameron, Prof Carlo Palmieri 
& Lesley Stephen


Morning Session
Chaired by Prof Andrew Tutt

9.45 - 10.30am

Talking to friends & family
Prof Dame Lesley Fallowfield 

10.30 - 11.00am


11.00 - 11.45am 

Precision medicine in secondary breast cancer
Dr Ciara O'Brien

11.45am - 12.30pm

Latest in TNBC News
Dr Sheeba Irshad 

12.30 - 1.30pm 



Afternoon Session
Chaired by Dr Marina Parton

1.30 - 2.15pm 

Coping with side effects
Sarah Adomah

2.15 - 3.00pm

Latest in HER2+ news
Prof David Cameron

3.00 - 3.30pm


3.30 - 4.15pm

Clinical Trials: what you need to know
Vivienne Wilson 

4.15 - 5.00pm

Latest in ER+ news 
Dr Sasha Howell



Thursday 11th July 



Morning Session
Chaired by Prof Carlo Palmieri

9.15 - 9.45am

Radiotherapy and local therapies
Naman Julka-Anderson


10.00 - 10.45am

Supportive and palliative care

Dr Daniel Monnery

10.45 - 11.15am


11.15am - 12.15pm

Living well with secondary breast cancer

Toral Shah - nutrition

Dr Catherine Harper-Wynne - Sleep & Exercise

12.00 - 1.00pm

Open Q&A session
Matthew Rowland
Phil Walker
Dr Marina Parton
Vivienne Wilson
Dr Conor Fitzpatrick
Prof Lesley Fallowfield
Lesley Stephen

1.00 - 1.15pm

Closing remarks
Prof Carlo Palmieri & Lesley Stephen

1.15 - 2.15pm


In partnership with:



Funding Partners

Thanks to our funding partners AstraZeneca UK ltd, Gilead Sciences ltd, Menarini Stemline Oncology, MSD, Novartis Pharmaceuticals UK ltd, 100 patient places are available, with accommodation and catering fully provided and a travel fund available to those who need support with travel expenses.